BC−/EC+ exhibited increased end-systolic and end-diastolic volume and decreased left ventricular function 3 weeks post MI. by Simone Gorressen (605474)

“…<p>BC−/EC+ exhibited an increase in end-systolic (<b>A</b>) and end-diastolic volume (<b>B</b>), a significantly more pronounced decrease in stroke volume (<b>C</b>) (BC+/EC+ n = 8 and BC−/EC+ n = 5; two-way ANOVA and Bonferroni’s post hoc test or student’s t-test; * p<0.05, ** p≤ 0.01 BC+/EC+ vs. …”

Ifit2 deficiency results in decreased neuroinflammation upon RSA59 infection. by Jayasri Das Sarma (652473)

Un- and refolding kinetics of CMPK wt – Chevron Plot and end point analysis. by Thorsten Beitlich (478192)

“…While the slow transitions show constant amplitudes (symbols like in (a)), the amplitude of the fast transition decreases and turns negative at 2.0 M urea. (c) End-point analysis of the unfolding and refolding transitions. …”

Efficacy end points. by Youngmin Ko (3333819)

Subjects:

Pitfalls of merging only considering end-points. by Almiqdad Elzein (13141038)

PowerPoint Slides for: Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis by Bushinsky D.A. (3246690)

Anesthetics differentially decrease cilia-driven particle transport speed (PTS). by Ghulam Murtaza (2559319)

Decrease of OA damage in T-VSCC KO vs. WT controls following <i>in vivo</i> knee loading. by Padma P. Srinivasan (745261)

Stable isotope biplots of end-members (colored points) faceted by coastscape and overlayed consumers (gray points). by Nathan D. McTigue (10706460)

Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

Ifit2 deficiency decreases CX3CR1 expression in microglia following infection. by Jayasri Das Sarma (652473)

NatB inactivation decreased the level of MAPK and proposed model of EGFR/MAPK signaling regulation by NatB and the N-end rule pathways. by Zhentao Sheng (107495)

“…<p>(A-B) <i>psid-D1</i> (A) or <i>psid-D4</i> (B) clones in 3rd instar fat body, which were marked by GFP expression (pointed by arrowheads), showed decreased MAPK levels (anti-MAPK staining, red). …”

ADMA levels decrease after PH of MMI-treated WT mice or TRβ KO and TRα+TRβ double KO mice. by Raquel López-Fontal (367920)

Co-expression of WT with M195T–WT decreases the stability of heteromers. by Cinzia Ambrosi (446348)

Subjects:

Knocking down of TRIM59 decreased the expression of cell cycle proteins. by Weihua Zhan (830500)

Tonic endocannabinoid signaling is decreased at cortical inhibitory synapses in Nlgn3^R451C mice. by Haley E. Speed (813995)

Hamster weight as an end-point for leptospiral infection. by Mariana L. Coutinho (337710)

“…</b> Control animals sham-immunized with phosphate-buffered saline (PBS) had stable or increasing weights until day 8 or 9 after challenge, after which they lost weight and met the end-point criterion of a 10% weight decrease (lines represent individual animals).…”

End-point variability and smallest effective ISS. by James P. Herman (304807)

“…<p>We define baseline end-point variability (σ_b) as: the standard deviation of primary saccade gain during the final 50 trials of the baseline phase. …”

Significant decrease in apoptosis was detected in the IL-1α or IL-1β deficient mice compared to WT mice after FHF induction. by Maya Sultan (2863391)

NatB-inactivation decreased Drk levels through its N-terminal sequences, which was regulated by the N-end rule E3 ubiquitin ligase POE/UBR4. by Zhentao Sheng (107495)

“…(C) Expression of WT Psid rescued the level of N-Drk-GFP in <i>psid-D4</i> mutant clones. …”